InvestorsHub Logo
Followers 59
Posts 11474
Boards Moderated 0
Alias Born 07/16/2006

Re: floblu14 post# 17828

Tuesday, 10/17/2017 6:20:54 PM

Tuesday, October 17, 2017 6:20:54 PM

Post# of 20689

Flo’s guesstimates - Select any 10:

1 Anniversary of Rick Shea’s departure
2 MNTA/Sandoz appeal Amphastar’s jury verdict. Settlement possible.
3 Shorts covering
4 M281 data expected in 2H 2017
5 M230 – Targeting phase 1 in 2017
6 M293 partnership by Y/E (Word might be out whom their partner is.)
7 Glatopa 40MG FDA approval imminent (I am repeating myself here smile )
8 Jbog goes LONG



#2 Yes it's possible. I doubt anything will favor Momenta.
#3 Probable
#4 Inmaterial
#5 Inmaterial
#6 Inmaterial
#7 That's a good one. Every day hurts because I would see no reason that if a patient is put on Generic X there would be any reason besides price they'd switch to Generic Y
#8 Yes, went long last Friday and I'll stick with it until it hits the $16 -$17 range.